Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Boris Johnson Says UK Underestimated Threat Posed by Covid-19.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Ashton, Emily (AUTHOR); Mayes, Joe (AUTHOR)
  • المصدر:
    Bloomberg.com. 12/6/2023, pN.PAG-N.PAG. 1p.
  • معلومة اضافية
    • الموضوع:
    • نبذة مختصرة :
      Former UK Prime Minister Boris Johnson admitted that his government underestimated the threat of Covid-19 in early 2020 and apologized for the suffering and loss experienced by the British people. During his testimony to the Covid-19 inquiry, Johnson defended himself against criticism of his handling of the pandemic and acknowledged the chaos and confusion in the early months of 2020. He acknowledged that mistakes may have been made in trying to balance the harms caused by the pandemic. Johnson's testimony followed months of criticism from senior officials and ministers. He also discussed issues such as the handling of WhatsApp messages, the gender balance in his team, and the decision to shake hands with Covid patients. Johnson rejected claims that the UK had the second worst level of excess deaths in Western Europe and cited the country's population density and elderly population as factors that made the situation more challenging. He also mentioned that his Cabinet was more reluctant to impose a lockdown than he was. Johnson's emotional testimony included an apology for the pain and loss suffered by the victims and their families. [Extracted from the article]
    • نبذة مختصرة :
      Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)